• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型信使核糖核酸双重免疫诱导固有转录特征,建立T细胞记忆并协调回忆反应。

SARS-CoV-2 mRNA Dual Immunization Induces Innate Transcriptional Signatures, Establishes T-Cell Memory and Coordinates the Recall Response.

作者信息

Papadatou Ioanna, Geropeppa Maria, Verrou Kleio-Maria, Tzanoudaki Marianna, Lagousi Theano, Liatsis Emmanouil, Spoulou Vana

机构信息

First Department of Paediatrics, Medical School, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Immunobiology and Vaccinology Research Lab, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

出版信息

Vaccines (Basel). 2023 Jan 1;11(1):103. doi: 10.3390/vaccines11010103.

DOI:10.3390/vaccines11010103
PMID:36679948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9861479/
Abstract

BACKGROUND

mRNA vaccines have played a crucial role in controlling the SARS-CoV-2 global pandemic. However, the immunological mechanisms involved in the induction, magnitude and longevity of mRNA-vaccine-induced protective immunity are still unclear.

METHODS

In our study, we used whole-RNA sequencing along with detailed immunophenotyping of antigen-specific T cells and humoral RBD-specific response to dual immunization with the Pfizer-BioNTech mRNA vaccine (BNT162b2) and correlated them with response to an additional dose, administered 10 months later, in order to comprehensively profile the immune response of healthy volunteers to BNT162b2.

RESULTS

Primary dual immunization induced upregulation of the Type I interferon pathway and generated spike protein (S)-specific IFN-γ+ and TNF-α+ CD4 T cells, S-specific memory CD4 T cells, and RBD-specific antibodies against SARS-CoV-2. S-specific CD4 T cells induced by the primary series correlated with the RBD-specific antibody titers to a third dose.

CONCLUSIONS

This study demonstrates the induction of both innate and adaptive immunity in response to the BNT162b2 mRNA vaccine in a coordinated manner and identifies the central role of primarily induced CD4+ T cells as a predictive biomarker of the magnitude of anamnestic immune response.

摘要

背景

mRNA疫苗在控制SARS-CoV-2全球大流行中发挥了关键作用。然而,mRNA疫苗诱导的保护性免疫的诱导、强度和持久性所涉及的免疫机制仍不清楚。

方法

在我们的研究中,我们使用全RNA测序以及对抗原特异性T细胞的详细免疫表型分析和对辉瑞- BioNTech mRNA疫苗(BNT162b2)双重免疫的体液RBD特异性反应,并将它们与10个月后给予的额外一剂疫苗的反应相关联,以便全面描绘健康志愿者对BNT162b2的免疫反应。

结果

初次双重免疫诱导了I型干扰素途径的上调,并产生了刺突蛋白(S)特异性IFN-γ+和TNF-α+ CD4 T细胞、S特异性记忆CD4 T细胞以及针对SARS-CoV-2的RBD特异性抗体。初次免疫系列诱导的S特异性CD4 T细胞与第三剂的RBD特异性抗体滴度相关。

结论

本研究证明了对BNT162b2 mRNA疫苗以协调方式诱导先天性和适应性免疫,并确定了主要诱导的CD4+ T细胞作为回忆性免疫反应强度的预测生物标志物的核心作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/c106fe146ef6/vaccines-11-00103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/f6b2f527cd95/vaccines-11-00103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/7dd7b8e41a18/vaccines-11-00103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/ef785da21362/vaccines-11-00103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/6443bc946e87/vaccines-11-00103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/6a683d2ede17/vaccines-11-00103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/c106fe146ef6/vaccines-11-00103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/f6b2f527cd95/vaccines-11-00103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/7dd7b8e41a18/vaccines-11-00103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/ef785da21362/vaccines-11-00103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/6443bc946e87/vaccines-11-00103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/6a683d2ede17/vaccines-11-00103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ce/9861479/c106fe146ef6/vaccines-11-00103-g006.jpg

相似文献

1
SARS-CoV-2 mRNA Dual Immunization Induces Innate Transcriptional Signatures, Establishes T-Cell Memory and Coordinates the Recall Response.严重急性呼吸综合征冠状病毒2型信使核糖核酸双重免疫诱导固有转录特征,建立T细胞记忆并协调回忆反应。
Vaccines (Basel). 2023 Jan 1;11(1):103. doi: 10.3390/vaccines11010103.
2
Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的信使核糖核酸(mRNA)免疫诱导的受体结合域特异性B细胞反应。
Vaccines (Basel). 2023 Jun 25;11(7):1148. doi: 10.3390/vaccines11071148.
3
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“法斯卡莱基金会”癌症中心(INT - IRCCS)医护人员接种BNT162b2 mRNA抗SARS-CoV-2疫苗后抗体滴度呈双峰下降
Infect Agent Cancer. 2022 Jul 28;17(1):40. doi: 10.1186/s13027-022-00451-1.
4
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.一种特定的抗新冠病毒BNT162b2疫苗诱导的早期先天免疫特征与健康和多发性硬化症疫苗接种者的体液保护反应呈正相关。
Clin Transl Immunology. 2023 Mar 23;12(3):e1434. doi: 10.1002/cti2.1434. eCollection 2023.
5
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.类风湿关节炎患者接种SARS-CoV-2 mRNA疫苗6个月后B细胞和T细胞免疫反应的动力学
Front Immunol. 2022 Feb 28;13:846753. doi: 10.3389/fimmu.2022.846753. eCollection 2022.
6
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.比较 BNT162b2 mRNA 疫苗接种者的恢复期和未接种者的 SARS-CoV-2 抗刺突蛋白 RBD IgG 和中和抗体与 COVID-19 患者的动力学。
BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6.
7
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy.使用同源或异源加强免疫策略,由第三剂BBIBP-CorV(国药集团)和BNT162b2(辉瑞-生物科技公司)疫苗引发的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体和T细胞反应
Vaccines (Basel). 2022 Mar 30;10(4):539. doi: 10.3390/vaccines10040539.
8
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.mRNA SARS-CoV-2 疫苗的第三剂加强了骨髓纤维化患者的刺突特异性抗体和记忆 B 细胞反应。
Front Immunol. 2022 Sep 29;13:1017863. doi: 10.3389/fimmu.2022.1017863. eCollection 2022.
9
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.健康成年人中,BBIBP-CorV(国药)和 BNT162b2(辉瑞-生物科技)疫苗对 SARS-CoV-2 诱导的抗体和 T 细胞应答的比较。
Geroscience. 2021 Oct;43(5):2321-2331. doi: 10.1007/s11357-021-00471-6. Epub 2021 Oct 11.
10
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.

引用本文的文献

1
Deciphering Immune Responses to Immunization via Transcriptional Analysis: A Narrative Review of the Current Evidence towards Personalized Vaccination Strategies.通过转录分析破译免疫接种的免疫反应:个性化疫苗接种策略的当前证据的叙述性综述。
Int J Mol Sci. 2024 Jun 28;25(13):7095. doi: 10.3390/ijms25137095.
2
Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的信使核糖核酸(mRNA)免疫诱导的受体结合域特异性B细胞反应。
Vaccines (Basel). 2023 Jun 25;11(7):1148. doi: 10.3390/vaccines11071148.

本文引用的文献

1
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations.在体弱人群中接种mRNA疫苗BNT162b2后的体液和T细胞介导反应。
Vaccine X. 2022 Dec;12:100246. doi: 10.1016/j.jvacx.2022.100246. Epub 2022 Dec 5.
2
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.接种第二剂 BNT162b2 疫苗后在日本社区的体液免疫:福岛疫苗接种社区调查的观察性横断面研究。
Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x.
3
Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron.
韩国队列中的异源ChAdOx1-BNT162b2疫苗接种可诱导包括奥密克戎在内的强烈免疫和抗体反应。
iScience. 2022 Jun 17;25(6):104473. doi: 10.1016/j.isci.2022.104473. Epub 2022 May 26.
4
Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2.预先存在的T细胞免疫决定了针对两剂SARS-CoV-2 mRNA疫苗的细胞免疫反应的频率和强度。
Vaccine X. 2022 Aug;11:100165. doi: 10.1016/j.jvacx.2022.100165. Epub 2022 May 2.
5
, Exploring its Roles in Cell Survival Under Stress Context.探索其在应激环境下细胞存活中的作用。
Front Cell Dev Biol. 2022 Apr 19;10:867003. doi: 10.3389/fcell.2022.867003. eCollection 2022.
6
Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.新冠病毒疾病 2019 信使 RNA 疫苗接种者对严重急性呼吸综合征冠状病毒 2 奥密克戎变异株的抗体和 T 细胞反应不一致。
Clin Infect Dis. 2022 Oct 29;75(9):1652-1654. doi: 10.1093/cid/ciac305.
7
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron.COVID-19 康复后 15 个月和 20 个月对 80 岁以上人群进行 mRNA 疫苗接种可引发强烈的免疫和抗体反应,其中包括奥密克戎。
Cell Rep. 2022 Apr 12;39(2):110680. doi: 10.1016/j.celrep.2022.110680. Epub 2022 Mar 25.
8
Homologous and Heterologous Covid-19 Booster Vaccinations.同源和异源 COVID-19 加强针接种。
N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.
9
Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for Accurate and Prompt Coronavirus Disease 2019 (COVID-19) Diagnosis Using the Rational Selection of Serological Biomarkers.通过合理选择血清学生物标志物开发用于准确快速诊断2019冠状病毒病(COVID-19)的酶联免疫吸附测定(ELISA)
Diagnostics (Basel). 2021 Oct 23;11(11):1970. doi: 10.3390/diagnostics11111970.
10
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.mRNA 疫苗可诱导对 SARS-CoV-2 及其关注变种的持久免疫记忆。
Science. 2021 Dec 3;374(6572):abm0829. doi: 10.1126/science.abm0829.